Skip to main content
eScholarship
Open Access Publications from the University of California

EVALUATION OF REINTUBATION RATES FOLLOWING INTRODUCTION OF NEW REVERSAL AGENT

The data associated with this publication are not available for this reason: N/A
Abstract

• Postoperative residual neuromuscular blockade is associated with post-op complications

• Current blockade reversal agents are Sugammadex and Neostigmine

• Sugammadex may decrease postoperative residual neuromuscular blockade

• Sugammadex was introduced to UC Davis Academic Center on 3/11/16

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View